2026年4月8日，杭州启明医疗器械股份有限公司（股票代码：02500）发布截至2026年3月31日的股份变动月报表。报告显示，公司本月已发行及注册股本未发生变化，其中普通股H股441,010,235股，非上市外资股1,208股，合计441,011,443股。
本月内无新增发行或回购注销活动。此前于2021年12月8日、17日及20日合计购回的3,114,000股H股仍处于待注销状态，未对当期已发行股份总数造成影响。此外，按计划授出的股份期权数量保持不变，未有行使或失效情况。公司确认截至报告期末符合香港联交所上市规则及相关法律法规的规定。
本次月报由公司执行董事柳美荣签署。公司表示，将继续严格按照监管要求履行信息披露义务，确保股东权益和市场透明度。若有进一步股份变动，公司将及时公告。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.